# VitriVax **Source:** https://www.startuphub.ai/startups/vitrivax **Profile type:** Startup > An innovative vaccine development and formulation technology company. ## About VitriVax is an innovative vaccine development and formulation technology company focused on advancing vaccine candidates, including a Lyme disease vaccine candidate with a novel mechanism of action. ## Key facts - **Slug:** vitrivax - **Website:** https://vitrivaxbio.com - **Location:** Boulder, Colorado, United States - **Employees:** 52 - **Operating status:** Active - **Total funding:** $104M - **Sectors / tags:** Biotechnology, Vaccines, Pharmaceuticals - **Social:** - LinkedIn: https://www.linkedin.com/company/vitrivax ## StartupHub.ai scores - **Ahrefs DR:** 34/100 - **Agent Readiness:** F (37/100) - **Site Speed:** 56/100 - **Data Trust:** 82/100 ## Funding rounds | Date | Round | Amount | Lead investors | | --- | --- | --- | --- | | 18 Nov 2026 | [Series C](https://www.startuphub.ai/investment_rounds/vitrivax-series-c-2026) | $87M | [F-Prime](https://www.startuphub.ai/investors/f-prime), [NEA](https://www.startuphub.ai/investors/nea), [RA Capital](https://www.startuphub.ai/investors/ra-capital), [Sanofi Ventures](https://www.startuphub.ai/investors/sanofi-ventures) | | 22 Oct 2025 | [Series B](https://www.startuphub.ai/investment_rounds/vitrivax-series-b-2025) | $17.3M | [RA Capital](https://www.startuphub.ai/investors/ra-capital) | ## Tech stack Detected on vitrivaxbio.com, last scanned 2026-11-18. - **Email provider:** Microsoft 365 ## JSON-LD Structured data aligned with this page's `